Monashee Investment Management LLC Alpine Immune Sciences, Inc. Transaction History

Monashee Investment Management LLC

  • $774 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$17.75 - $41.6 $394,866 - $925,433
-22,246 Reduced 29.74%
52,546 $2.08 Million
Q4 2023

Feb 12, 2024
BUY
$8.54 - $20.22 $638,723 - $1.51 Million
74,792 New
74,792 $1.43 Million
Q3 2022

Nov 01, 2022
BUY
$6.89 - $9.39 $689,000 - $939,000
100,000 New
100,000 $720,000
Q2 2021

Aug 12, 2021
SELL
$8.81 - $15.03 $261,234 - $445,669
-29,652 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$7.15 - $11.5 $212,011 - $340,998
29,652 New
29,652 $4,000

Others Institutions Holding ALPN

# of Institutions
2
Shares Held
56.2K
Call Options Held
0
Put Options Held
0
View Full List

About ALPINE IMMUNE SCIENCES, INC.

ALPN Quotes by TradingView
  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email